Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/2012
06/28/2012US20120165285 Combined preparation for use as a medicament
06/28/2012US20120165281 Stilbenoid derivatives and their uses
06/28/2012US20120165252 Method of Regulating Glucose Metabolism, and Reagents Related Thereto
06/28/2012US20120165251 Diabetes therapy
06/28/2012US20120164265 Dietary Method for Modulating Glucose Metabolism
06/28/2012US20120164252 Supplement comprising blackcurrants or boysenberries
06/28/2012US20120164243 Compositions and Methods for Improving Mitochondrial Function and Treating Neurodegenerative Diseases and Cognitive Disorders
06/28/2012US20120164227 New granulating process and thus prepared granulate
06/28/2012US20120164226 Compositions and Methods for Improving Prognosis of a Human with Subarachnoid Hemorrhage
06/28/2012US20120164221 Combinations of hmg-coa reductase inhibitors and nicotinic acid compounds and methods for treating hyperlipidemia once a day at night
06/28/2012US20120164212 Stem cell beacon
06/28/2012US20120164186 Diketopiperazine Microparticles with Defined Specific Surface Areas
06/28/2012US20120164185 Oral nutrient or medicant carrier having increased surface area and absorption rate
06/28/2012US20120164181 Non-Specific Immunostimulating Agents
06/28/2012US20120164161 Antibodies and Uses Thereof
06/28/2012US20120164159 Humanised Antibodies to Toll-Like Receptor 2 and Uses Thereof
06/28/2012US20120164154 Method for increasing insulin sensitivity and for treating and preventing type 2 diabetes
06/28/2012US20120164140 Hemojuvelin fusion proteins and uses thereof
06/28/2012US20120164139 Dopamine 3 receptor agonist and antagonist treatment of gastrointestinal motility disorders
06/28/2012US20120164138 Use of anti-cd1 antibodies for the modulation of immune responses
06/28/2012US20120164132 Anticancer and immunomodulating molecules and fractions containing said molecules, and process for preparing said fractions and said molecules from fermented vegetal material, and their uses
06/28/2012US20120164131 Modified mutant collagenase and it's use in fat melting and in scar reduction
06/28/2012US20120164122 Phytoestrogenic formulations for alleviation or prevention of neurodegenerative diseases
06/28/2012US20120164120 Novel monascuspurpurones, preparation process thereof, and uses of the monascuspurpurones
06/28/2012US20120164114 Treatment of immune-related diseases and disorders using amnion derived adherent cells
06/28/2012US20120164113 Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof
06/28/2012US20120164072 Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery
06/28/2012US20120164070 Benzothiazole and benzooxazole derivatives and methods of use
06/28/2012CA2845524A1 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof
06/28/2012CA2822767A1 Polymorphs of 3-chloro-4[(2r)-2-(4-chlorophenyl)-4-[(1r)-1-(4-cyanophenyl)ethyl]-1-piperazinyl]-benzonitrile, pharmaceutical compositions and method of use comprising said polymorphs, and a process for preparing them
06/28/2012CA2822617A1 Methods for treating metabolic disorders and obesity with gip and glp-1 receptor-active glucagon-based peptides
06/28/2012CA2822265A1 Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
06/28/2012CA2822213A1 Combination and composition for treating obesity
06/28/2012CA2822017A1 Glucagon receptor modulators
06/28/2012CA2821861A1 Composition comprising cinnamon extract
06/28/2012CA2821807A1 Methods and compositions suitable for managing blood glucose in animals
06/28/2012CA2819825A1 Compositions and methods for modulating fxr
06/27/2012EP2468858A1 Fusion protein regulating plasma glucose and lipid, its preparation method and use
06/27/2012EP2468737A1 Sulfone derivative
06/27/2012EP2468361A1 Vildagliptin Formulations
06/27/2012EP2468258A1 Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
06/27/2012EP2468256A1 Combinations of vildagliptin and glimepiride
06/27/2012EP2468253A1 Terpenoid spiro ketal compounds with LXR agonists activity, their use and formulations with them
06/27/2012EP2467378A2 Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same
06/27/2012EP2467366A1 Novel fxr (nr1h4 ) binding and activity modulating compounds
06/27/2012EP2467362A2 Phosphatidylcholine transfer protein inhibitors
06/27/2012EP2467160A2 Materials and methods for the development of an antigen-specific immune non-responsiveness state
06/27/2012EP2467152A1 Use of nkg2d inhibitors for treating cardiovascular and metabolic diseases, such as type 2 diabetes
06/27/2012EP2467145A1 Compositions containing mixtures of fermentable fibers
06/27/2012EP2467135A2 Desferrioxamine-metal complexes for the treatment of immune-related disorders
06/27/2012EP2280952B1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
06/27/2012EP2246360B1 Compositions for the treatment of gastrointestinal disorders
06/27/2012EP2215089B1 [1h- pyrazolo [3, 4-b]pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase c-theta
06/27/2012EP2202216B1 Spiro-ring compound and use thereof for medical purposes
06/27/2012EP2188263B1 Benzimidazole derivatives used as fxr agonists
06/27/2012EP2125735B1 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
06/27/2012EP2097079B1 Modulation of prostaglandin/cyclooxygenase metabolic pathways
06/27/2012EP2023939B1 Compounds and methods for modulating expression of pcsk9
06/27/2012EP2007729B1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
06/27/2012EP1985296B1 New substituted pentabasic azaheterocyclic compounds and its use of treating protein aging disease
06/27/2012EP1984340B1 Anthranilamide/2-amino-heteroarene carboxamide derivatives
06/27/2012EP1968644B1 Polymer conjugates of glp-1
06/27/2012EP1734946B1 Punicic acid for use to enhance immune response and treating inflammatory bowel disease
06/27/2012EP1698624B1 Phenylpropanoic acid derivatives
06/27/2012EP1389611B1 20-hydroxyeicosatetraenoic acid production inhibitors
06/27/2012CN1724519B Indole kind compound with insuline sensitizing activity and its preparation method and use
06/27/2012CN102516404A Preparation method of rosuvastatin-dextran ester
06/27/2012CN102516393A Insulin mimetic peptide fusion protein, mutant and applications thereof
06/27/2012CN102516352A Smilagenin in crystalline and amorphous forms
06/27/2012CN102516263A Spirotricyclic compound, its preparation method, and pharmaceutical composition containing it as well as application thereof
06/27/2012CN102516240A Heteroaryl-ureas and their use as glucokinase activators
06/27/2012CN102516219A Halogenated polyhydroxy xanthene derivatives, preparation method and use thereof
06/27/2012CN102516166A Nicotinic acid derivative of fenofibrate and preparation method of nicotinic acid derivative
06/27/2012CN102516150A Crystalline forms of fluvastatin sodium
06/27/2012CN102516115A Novel compounds as antagonists or inverse agonists at opioid receptors
06/27/2012CN102516079A Novel ferulic acid derivative, its application and synthetic method
06/27/2012CN102512679A Combination comprising s-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]2-methylpropanethioate and an hmg coa reductase inhibitor
06/27/2012CN102512678A Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
06/27/2012CN102512655A L-carnitine composition, L-carnitine preparation and preparation method and application thereof
06/27/2012CN102512648A Traditional Chinese drug composition for treatment and prevention of metabolic syndrome
06/27/2012CN102512591A Composition with functions of losing weight and reducing blood glucose and lipid
06/27/2012CN102512584A Chinese medicinal pill for treating diabetic complications
06/27/2012CN102512576A Asparagus tuber vacuum freeze-drying processing method
06/27/2012CN102512567A Dropping pill medicinal preparation for treating diabetes mellitus and preparation method
06/27/2012CN102512561A Traditional Chinese medicine spleen-tonifying and blood lipid-lowering decoction for treating spleen deficiency phlegm accumulation-type hyperlipemia
06/27/2012CN102512520A Normal-temperature preparation method for ultrafine powder hawthorn and special bilateral airflow sieving machine thereof
06/27/2012CN102512518A Chinese medicinal extract for treating diabetic peripheral neuropathy and preparation method thereof
06/27/2012CN102512507A Application of rheum australe extract to preparation of medicament for preventing and treating diabetes
06/27/2012CN102512482A Euonymus alatus extract, blood-sugar-reducing activity thereof and application of euonymus alatus extract to preparation of products for reducing blood sugar
06/27/2012CN102512473A Stevia rebaudiana bertoni phenol extract, blood-sugar-reducing activity thereof and application of stevia rebaudiana bertoni phenol extract to preparation of products for reducing blood sugar
06/27/2012CN102512461A Preparation method for silicon compound of Equisetum
06/27/2012CN102512458A Semi-bionic extraction method for active components of Cordyceps militaris
06/27/2012CN102512456A Propolis soft capsule content and preparation method thereof
06/27/2012CN102512445A Multivitamin mineral preparation
06/27/2012CN102512442A Zinc chelate-containing compound vitamin oral nano-emulsion and preparation method for same
06/27/2012CN102512438A Application of pseudostellaria polysaccharide in food for preventing and treating diabetes mellitus as well as health-caring
06/27/2012CN102512437A Medicinal composition of liposoluble vitamin injection (I) and water-soluble vitamin for injection and preparation method thereof
06/27/2012CN102512426A Application of ursolic acid in preparation of health care product with effects of weight loss and fatty liver improvement
06/27/2012CN102512425A Preparation method of inclusion compound of ursolic acid and schardinger dextrin
06/27/2012CN102512409A Medical preparation containing levocarnitine and dihydroxybenzenesulphonic acid salt and preparation method of medical preparation
1 ... 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 ... 1298